ONCOLYTICS BIOTECH INC (ONC.CA) Stock Balance Sheet
TSX:ONC - CA6823108759 - Common Stock
1.42 CAD
+0.03 (+2.16%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 4.06M | 15.94M | 3.38M | 11.67M | 1.36M | |||
| Marketable Securities | 11.59M | 13.29M | 31.53M | 20.47M | 39.90M | |||
| Receivables | 72.00K | 68.00K | 15.00K | 520.00K | 870.00K | |||
| Other Current Assets | 3.17M | 1.89M | 3.25M | 3.03M | 2.78M | |||
| Total Current Assets | 18.90M | 18.88M | 38.17M | 35.68M | 44.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.08M | 1.31M | 647.00K | 650.00K | 980.00K | |||
| Other Non-Current Assets | N/A | N/A | 0.00 | 1.00M | N/A | |||
| Total Non-Current Assets | 1.08M | 1.31M | 647.00K | 1.65M | 980.00K | |||
| TOTAL ASSETS | 19.97M | 20.19M | 38.82M | 37.33M | 45.88M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 291.00K | 277.00K | 133.00K | 220.00K | 290.00K | |||
| Accrued Expenses | 3.95M | 3.71M | 2.49M | N/A | N/A | |||
| Accounts Payable | 1.33M | 5.88M | 1.08M | 3.65M | 1.99M | |||
| Other Current Liabilities | 982.00K | 1.62M | 532.00K | 80.00K | 410.00K | |||
| Total Current Liabilities | 6.56M | 6.69M | 4.24M | 3.95M | 2.69M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 597.00K | 787.00K | 290.00K | 160.00K | 360.00K | |||
| Other Non-Current Liabilities | 6.73M | 6.73M | 6.73M | 6.73M | 6.73M | |||
| Total Non-Current Liabilities | 7.33M | 7.52M | 7.02M | 6.88M | 7.09M | |||
| TOTAL LIABILITIES | 13.88M | 14.20M | 11.26M | 10.83M | 9.78M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -490.56M | -477.71M | -446.00M | -418.25M | -393.42M | |||
| Additional Paid In Capital | 44.79M | 44.54M | 42.12M | 40.05M | 37.78M | |||
| Common Shares | 451.14M | 438.19M | 430.91M | 404.04M | 391.35M | |||
| Other Shareholders' Equity | 720.00K | 961.00K | 544.00K | 660.00K | 390.00K | |||
| Shares Outstanding | 97.41M | 80.02M | 74.42M | 61.33M | 55.04M | |||
| Tangible Book Value per Share | 0.06 | 0.07 | 0.37 | 0.43 | 0.66 | |||
| Total Shareholders' Equity | 6.09M | 5.98M | 27.56M | 26.50M | 36.10M | |||
| TOTAL LIABILITIES AND EQUITY | 19.97M | 20.19M | 38.82M | 37.33M | 45.88M | |||
| Statistics | ||||||||
| Debt/Equity | 0.10 | 0.13 | 0.01 | 0.01 | 0.01 | |||
| Current Ratio | 2.88 | 2.82 | 9.01 | 9.03 | 16.69 | |||
| Return On Assets (ROA) | -152.26% | -157.08% | -71.49% | -66.54% | -57.32% | |||
| Return On Equity (ROE) | -499.46% | -530.00% | -100.69% | -93.74% | -72.85% | |||
All data in CAD , ROIC based on taxRate of 0.28